Reported Earlier: Kura Oncology And Kyowa Kirin To Present Eight Ziftomenib Abstracts At ASH 2026, Highlighting Promising AML Combination Data And Expanded Clinical Potential

Benzinga

2026.11.04 17:53 (GMT+0)

Benzingaで開く